Hurkmans, Daan P. http://orcid.org/0000-0002-8750-5188
Kuipers, Merian E.
Smit, Jasper
van Marion, Ronald
Mathijssen, Ron H. J.
Postmus, Piet E.
Hiemstra, Pieter S.
Aerts, Joachim G. J. V.
von der Thüsen, Jan H.
van der Burg, Sjoerd H.
Funding for this research was provided by:
Stichting Zabawas
Bristol-Myers Squibb (OT123-361)
Article History
Received: 27 September 2019
Accepted: 28 January 2020
First Online: 12 February 2020
Compliance with ethical standards
:
: J.G.J.V. Aerts and P.E. Postmus have an advisory role for Bristol-Myers Squibb, J.H. von der Thüsen received research funding from Bristol-Myers Squibb. The authors declare that there are no other conflicts of interest.
: Trial number and trial registration details: MULTOMAB trial, Dutch Trial Register number NTR7015/ NL6828, ethics approval by responsible authority Medical Research Ethics Committee Erasmus MC, reference number: 16-011. The use of archival FFPE samples was in accordance with guidelines from the Dutch Federation of Medical Research and was approved by responsible authority Medical Research Ethics Committee Erasmus MC, reference number: 17-1186.
: All patients signed written informed consent to use data and materials for research and publication, which was provided before study entry (MULTOMAB trial, NTR7015/NL6828).